Management of Radiation Side Effects: Deciphering What Advanced Practice Providers Really Want to Know

December 15, 2020 - December 15, 2021


This activity was originally presented at an APP Oncology Summit in 2020. The APP Oncology Summit is a two-day conference designed to provide advanced practice providers (APPs) with the latest evidenced-based strategies to optimize care and outcomes for patients with cancer. This conference is planned with and for advanced practice providers (NPs, PAs, pharmacists, and nurse specialists) and is a collaborative effort of oncology clinicians from multiple organizations in each community. APP Oncology Summit offers a unique opportunity for APPs from various healthcare teams in the community to collaborate, learn from each other and national faculty, and share best practices on a range of issues related to the care of cancer patients.

Target Audience
This activity has been designed to meet the educational needs of oncology nurse practitioners (NPs), physician assistants (PAs), nurse specialists, and other health care providers involved in the management of oncology patients.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Identify the acute and late side effects associated with radiation therapy
  • Summarize the monitoring parameters and treatment options to use for specific radiation‐induced toxicities

Activity Launch Date - 12/15/2020
Expiration Date - 12/15/2021

Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Statement of Independence
Horizon CME educational activities are developed and conducted in accordance with the ACCME's Essential Areas and Policies. It is the mission of Horizon CME to develop and present educational activities that are timely, fair balanced, scientifically rigorous, and that serve to improve patient outcomes. To that end, we welcome comments about how to better serve your needs.

Copyright Information
Copyright © 2020 by Horizon CME. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from Horizon CME.


Time Description
31 min

Webcast: Management of Radiation Side Effects: Deciphering What Advanced Practice Providers Really Want to Know

9 min

Final Evaluation

Faculty & Disclosures

Randy L. Wei, MD, PhD
Radiation Oncologist
Memorial Radiation Oncology Medical Group
Long Beach, CA

Faculty Bio

As a radiation oncologist, Dr. Wei’s clinical practice focuses on the comprehensive care of children and adults with cancer. Dr. Wei received his medical and graduate degrees at the University of California, Irvine, as part of the Medical Scientist Training Program. He then completed his internal medicine internship and radiation oncology residency at the University of California, Irvine. He trained with Dr. Nisar Syed and Dr. Ajmel Puthawala in interstitial brachytherapy and hyperthermia techniques. He served as Chief Resident for the final 2 years of residency.

Dr. Wei recognizes the unique needs of cancer patients and their families after his own father was treated for head and neck cancer. His philosophy on care is to empower his patients with education on their cancer and treatment options, enable patients and caregivers to make informed medical decisions, and provide them access to the most advanced radiation treatments such as intensity modulated radiotherapy, stereotactic radiosurgery, interstitial brachytherapy, and proton therapy.

Over the past decade, Dr. Wei has published over 21 peer reviewed manuscripts and 3 book chapters in journals such as Radiotherapy and Oncology, Practical Radiation Oncology, Medical Dosimetry, and Molecular and Cell Biology. His clinical interests are in cancer biology, pediatrics, brachytherapy, quality and safety, and palliative care. Dr. Wei received his PhD from the lab of Dr. Wen-Hwa Lee who cloned the retinoblastoma tumor suppressor gene, and did pioneering research on the mechanism of tumor suppressors in cancers. He has given oral presentations at the American Society for Radiation Oncology (ASTRO) and Radiological Society of North American (RSNA) Annual Meeting, and he was awarded the American Society for Clinical Oncology Conquer Cancer Foundation Award, and RSNA Roentgen Research Award.

Dr. Wei is a member of ASTRO, Los Angeles Radiological Society, American College of Radiation Oncology, and American Brachytherapy Society. In addition, he volunteers on the Medical Advisory Board for Make-A-Wish Orange County and Imperial Empire. Dr. Wei is on the medical staff at Long Beach and Saddleback Memorial Medical Center.

Faculty Disclosure Statement
Dr. Randy Wei discloses no relevant financial relationships with any entity producing, marketing, reselling, or distributing health care goods or services consumed by or used on patients during the past 12 months.

Planning Committee & Non-faculty Contributors

  • Beth Faiman has served as a consultant for Celgene and Karyopharm.
  • Dr. Val Adams has served as a consultant for Amgen.

All other nonfaculty contributors involved in the planning, development, and editing or review of the content disclosed no relevant financial relationships with any entity producing, marketing, reselling, or distributing health care goods or services consumed by or used on patients during the past 12 months.

Learner Assurance Statement
Horizon CME requires instructors, planners, managers and other individuals who are in a position to influence the content of this activity to disclose any real or apparent conflict of interest (COI) which may arise as a result of prospective faculty members' relevant relationships with drug or device manufacturer(s). Horizon CME is committed to resolving all conflicts of interest and retaining only those speakers with financial interest conflicts that can be reconciled with the goals and educational integrity of the CME activity.

CE Information

Launch Date/Expiration Date
This activity was launched on December 15, 2020 and will expire on December 15, 2021.

Accreditation Statement

Horizon CME is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
Horizon CME designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

How To Claim Credit

  • There are no fees to participate in the activity.
  • Participants must review all activity information, including the learning objectives, disclosure statements, and content.
  • To receive CME credit, participants must complete the activity and the post-activity evaluation.
  • Certificates can be printed immediately.

Any questions? Please check out our FAQs section or feel free to contact us.